Screener
Eligibility screening
EF-41/KEYNOTE D58: Phase 3 Trial of Optune With Temozolomide and Pembrolizumab
30 US sites in AZ, CA, FL, IL +15
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.
Screener
EF-41/KEYNOTE D58: Phase 3 Trial of Optune With Temozolomide and Pembrolizumab
30 US sites in AZ, CA, FL, IL +15
Before we begin
Your answer affects how the questions are phrased.